Spectral AI, Inc. (MDAI)
1.855
0.00 (0.00%)
USD |
NASDAQ |
Jun 10, 16:00
1.845
-0.01
(-0.54%)
After-Hours: 20:00
Spectral AI Enterprise Value : 57.48M for June 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 09, 2026 | 57.48M |
| June 08, 2026 | 57.16M |
| June 05, 2026 | 58.43M |
| June 04, 2026 | 62.25M |
| June 03, 2026 | 60.02M |
| June 02, 2026 | 63.84M |
| June 01, 2026 | 62.89M |
| May 29, 2026 | 64.16M |
| May 28, 2026 | 71.80M |
| May 27, 2026 | 71.80M |
| May 26, 2026 | 73.71M |
| May 22, 2026 | 83.57M |
| May 21, 2026 | 82.30M |
| May 20, 2026 | 75.62M |
| May 19, 2026 | 73.71M |
| May 18, 2026 | 69.57M |
| May 15, 2026 | 75.62M |
| May 14, 2026 | 66.07M |
| May 13, 2026 | 63.20M |
| May 12, 2026 | 66.70M |
| May 11, 2026 | 72.43M |
| May 08, 2026 | 71.80M |
| May 07, 2026 | 69.89M |
| May 06, 2026 | 68.93M |
| May 05, 2026 | 70.52M |
| Date | Value |
|---|---|
| May 04, 2026 | 70.52M |
| May 01, 2026 | 66.70M |
| April 30, 2026 | 63.52M |
| April 29, 2026 | 60.02M |
| April 28, 2026 | 61.29M |
| April 27, 2026 | 60.66M |
| April 24, 2026 | 56.84M |
| April 23, 2026 | 55.57M |
| April 22, 2026 | 56.84M |
| April 21, 2026 | 55.25M |
| April 20, 2026 | 58.43M |
| April 17, 2026 | 58.43M |
| April 16, 2026 | 58.43M |
| April 15, 2026 | 59.07M |
| April 14, 2026 | 61.61M |
| April 13, 2026 | 57.16M |
| April 10, 2026 | 53.34M |
| April 09, 2026 | 51.43M |
| April 08, 2026 | 51.75M |
| April 07, 2026 | 50.47M |
| April 06, 2026 | 51.11M |
| April 02, 2026 | 44.43M |
| April 01, 2026 | 44.11M |
| March 31, 2026 | 45.06M |
| March 30, 2026 | 41.16M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Co-Diagnostics, Inc. | 10.01M |
| Fractyl Health, Inc. | 103.01M |
| NovelStem International Corp. | 1.979M |
| IGC Pharma, Inc. | 28.85M |
| Omnicell, Inc. | 1.762B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.412M |
| Revenue (Quarterly) | 3.991M |
| Total Expenses (Quarterly) | 7.403M |
| EPS Diluted (Quarterly) | -0.1074 |
| Gross Profit Margin (Quarterly) | 50.79% |
| Profit Margin (Quarterly) | -85.49% |
| Earnings Yield | -28.82% |
| Normalized Earnings Yield | -24.91 |